半岛bd体育手机客户端 说明
包装
5, 25 mg in glass bottle
生化/生理作用
SC-51089 is a selective EP1prostanoid receptor antagonist.
特点和优势
This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
法律信息
Sold for research purposes under agreement from Pfizer Inc.
Pfizer is a registered trademark of Pfizer, Inc.
基本信息
| 经验(实验)分子式 | C22H19ClN4O3·HCl · xH2O |
| 分子量 | 459.33 (anhydrous basis) |
| MDL编号 | MFCD17215974 |
| PubChem化学物质编号 | 329823723 |
| NACRES | NA.77 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| manufacturer/tradename | Pfizer? |
| 颜色 | white to off-white |
| 溶解性 | DMSO: ≥10 mg/mL |
| 创始人 | Pfizer |
| 储存温度 | room temp |
| SMILES string | O.Cl.Clc1ccc2Oc3ccccc3CN(C(=O)NNC(=O)CCc4ccncc4)c2c1 |
| InChI | 1S/C22H19ClN4O3.ClH.H2O/c23-17-6-7-20-18(13-17)27(14-16-3-1-2-4-19(16)30-20)22(29)26-25-21(28)8-5-15-9-11-24-12-10-15;;/h1-4,6-7,9-13H,5,8,14H2,(H,25,28)(H,26,29);1H;1H2 |
| InChI key | UEAWIGPAXPGSJC-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Danger |
| 危险声明 | H301 - H315 - H319 - H335 |
| 预防措施声明 | P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
Sigma-Aldrich
m.cnreagent.com
